Effect of pravastatin on newly-secreted very low density lipoprotein composition in rats.
Yoshino
G
G
Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
Matsushita
M
M
Iwai
M
M
Morita
M
M
Matsuba
K
K
Hirano
T
T
Furukawa
S
S
Kazumi
T
T
Baba
S
S
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D006538:Heptanoic Acids / Q000494:pharmacology*; D008079:Lipoproteins, VLDL / Q000097:blood / Q000378:metabolism*; D008297:Male; D009281:Naphthalenes / Q000494:pharmacology*; D010743:Phospholipids / Q000097:blood; D011092:Polyethylene Glycols / Q000494:pharmacology; D017035:Pravastatin; D051381:Rats; D011919:Rats, Inbred Strains; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D002914:Chylomicrons; D006538:Heptanoic Acids; D008079:Lipoproteins, VLDL; D009281:Naphthalenes; D010743:Phospholipids; D014280:Triglycerides; D011092:Polyethylene Glycols; D002784:Cholesterol; D017035:Pravastatin; C016811:tyloxapol